RBOT - Vicarious Surgical Inc.
After hours:
Chart Events
Momentum
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 2.2000 |
| Open | 2.2500 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's Range | 2.1800 - 2.2800 |
| 52 Week Range | 1.3600 - 4.7600 |
| Volume | |
| Avg. Volume | 345,104 |
| Market Cap | 279.171M |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5500 |
| Earnings Date | May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
Fair Value
Related Research
Business WireVicarious Surgical Announces Promotion of John Mazzola to Chief Operating Officer
WALTHAM, Mass., May 18, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer.
Business WireVicarious Surgical Reports First Quarter 2023 Financial Results
WALTHAM, Mass., May 08, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended March 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, May 8, 2023.
Business WireVicarious Surgical Earns Recognition from Fast Company and MedTech Breakthrough Awards
WALTHAM, Mass., May 04, 2023--Vicarious Surgical, Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough Awards for two industry awards:
Business WireVicarious Surgical to Report First Quarter 2023 Financial Results on May 8, 2023
WALTHAM, Mass., April 24, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2023, after the market closes on Monday, May 8, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Business WireVicarious Surgical to Participate in Upcoming Conferences
WALTHAM, Mass., February 22, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following upcoming investor conferences.
Business WireVicarious Surgical Reports Fourth Quarter and Full Year 2022 Financial Results
WALTHAM, Mass., February 13, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended December 31, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, February 13, 2023.
Business WireVicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023
WALTHAM, Mass., January 30, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Business WireVicarious Surgical Announces Changes to Board of Directors
WALTHAM, Mass., January 23, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors ef
Business WireVicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System
WALTHAM, Mass., December 22, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives from leading healthcare provider Uni
Business WireVicarious Surgical Partners with Renowned Surgeon to Successfully Perform Two Cadaveric Ventral Hernia Procedures
WALTHAM, Mass., November 17, 2022--Vicarious Surgical Inc. ("Vicarious Surgical'' or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that renowned surgeon Igor Belyansky, MD, used the Vicarious Surgical Beta 2 prototype, to successfully perform two cadaveric ventral hernia repair procedures.
Business WireVicarious Surgical System Named to TIME’s List of the Best Inventions of 2022
WALTHAM, Mass., November 10, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the outcomes, cost, and efficiency of surgical procedures, today announced their robotic system has been named one of TIME’s Best Inventions of 2022. The Vicarious Surgical robot was recognized in the experimental inventions category of TIME’s annual list, which features 200 extraordinary innovations changing our lives.
Business WireVicarious Surgical Reports Third Quarter 2022 Financial Results
WALTHAM, Mass., November 07, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, November 7, 2022.
Business WireVicarious Surgical Announces Memorandum of Understanding Agreement with Pittsburgh CREATES to Advance System Design
WALTHAM, Mass., November 07, 2022--Vicarious Surgical Inc. ("Vicarious Surgical'' or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it has signed a collaborative Memorandum of Understanding ("MOU") agreement with Pittsburgh CREATES, an innovation center that fosters collaborations between surgeons and healthcare professionals, with the academic and clinical resources of parent institutions, the Univ
Business WireVicarious Surgical to Report Third Quarter 2022 Financial Results on November 7, 2022
WALTHAM, Mass., October 24, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter 2022 after the market closes on Monday, November 7, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Business WireVicarious Surgical Announces Upcoming Beta 2 Demonstration Day
WALTHAM, Mass., October 13, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that it will host a Demonstration Day of its Beta 2 surgical robot prototype for investors and analysts starting at 11:00 a.m. ET on Tuesday, December 6, 2022, at its Waltham, MA headquarters. Further details will be released closer to the event.
Business WireVicarious Surgical to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
WALTHAM, Mass., August 17, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 11:30 am ET.
Business WireVicarious Surgical Reports Second Quarter 2022 Financial Results
WALTHAM, Mass., August 08, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2022. Management will host a corresponding conference call at 4:30 p.m. ET today, August 8, 2022.
Business WireVicarious Surgical to Present at the Canaccord Genuity 42nd Annual Growth Conference
WALTHAM, Mass., July 27, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in the Canaccord Genuity 42nd Annual Growth Conference.
Business WireVicarious Surgical to Report Second Quarter 2022 Financial Results on August 8, 2022
WALTHAM, Mass., July 25, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter 2022 after the market closes on Monday, August 8, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
Business WireVicarious Surgical Announces Center of Excellence Agreements with HCA Healthcare and UH Ventures to Advance System Design
Waltham, Mass., July 07, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it has signed collaborative Center of Excellence ("COE") agreements with both HCA Healthcare, one of the nation’s leading providers of healthcare services comprising 182 hospitals, and University Hospitals Ventures, the innovation and commercialization arm of University Hosp
Business WireVicarious Surgical Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
WALTHAM, Mass., June 21, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced it is set to join the broad-market Russell 3000® Index as well as the Russell 2000® and Russell Microcap® Indexes at the conclusion of the 2022 Russell indexes annual reconstitution, according to a preliminary list of additi
Business WireVicarious Surgical to Present at the Cowen 7th Annual FutureHealth Conference
WALTHAM, Mass., June 08, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in a virtual fireside chat at the Cowen 7th Annual FutureHealth Conference.